0 Comentários
0 Compartilhamentos
234 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Bladder Cancer Immunotherapy Market Set to Reach USD 29.75 Billion by 2036The global bladder cancer immunotherapy market is projected to reach USD 29.75 billion by 2036, rising from USD 11.44 billion in 2026 at a 10.0% CAGR, according to Fact.MR analysis. The market is expanding as immune checkpoint inhibitors gain broader use across first- and second-line treatment settings for advanced urothelial carcinoma. The forecast represents an absolute dollar opportunity of...0 Comentários 0 Compartilhamentos 276 Visualizações 0 Anterior
-
Breast Cancer Immunotherapy Market – Precision Immune Approaches Reshaping Oncology CareMarket Overview The breast cancer immunotherapy market is expanding rapidly as checkpoint inhibitors, antibody-drug conjugates, and emerging cellular therapies move beyond triple-negative subtypes into broader clinical use. Oncologists increasingly incorporate immune-based approaches alongside chemotherapy and targeted agents, reflecting a shift toward personalized treatment strategies guided...0 Comentários 0 Compartilhamentos 360 Visualizações 0 Anterior
-
Cancer Immunotherapy Market Future Opportunities in Targeted Cancer CareThe Cancer Immunotherapy Market is characterized by intense competition and a trend toward strategic alliances between key players. With intellectual property being a significant driver of value, companies are forming complex cross-licensing agreements to share technology and accelerate pipeline development. This cooperative competition is beneficial for the market as a whole, as it reduces...0 Comentários 0 Compartilhamentos 475 Visualizações 0 Anterior
-
CAR-T Cell Therapy Treatment Market Growth Driven by Rising Cancer Prevalence and Advanced ImmunotherapyAccording to the latest report published by Data Bridge Market Research, the CAR-T Cell Therapy treatment Market CAGR Value The global CAR-T Cell Therapy Treatment market size was valued at USD 10.89 billion in 2024 and is expected to reach USD 102.21 billion by 2032, at a CAGR of 32.30% during the forecast period This CAR-T Cell Therapy...0 Comentários 0 Compartilhamentos 693 Visualizações 0 Anterior
-
How CD47 Antibody Therapies Are Advancing Cancer Immunotherapy, Autoimmune Disease Treatment, and Personalized MedicineThe global leukocyte surface antigen CD47 antibody market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of cancer and improve patient outcomes. The market was valued at USD 1.3 billion in 2025 and is projected to reach USD 3.5 billion by 2035, growing at a CAGR of 10.6%. The...0 Comentários 0 Compartilhamentos 328 Visualizações 0 Anterior
-
How Cell Therapy Manufacturing Is Advancing Cancer Immunotherapy, Regenerative Medicine, and Personalized Treatment SolutionsThe global cell therapy manufacturing market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of complex diseases and improve patient outcomes. The market was valued at USD 13.17 billion in 2024 and is projected to reach USD 47.6 billion by 2032, growing at a CAGR of 17.42%. The...0 Comentários 0 Compartilhamentos 469 Visualizações 0 Anterior
-
How Rising Cancer Immunotherapy Demand and Genetic Engineering Advancements Are Driving the Chimeric Fusion Protein MarketThe global Chimeric Fusion Protein market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of cancer and improve patient outcomes. The market was valued at USD 21.31 billion in 2023 and is projected to reach USD 85.4 billion by 2032, growing at a CAGR of 16.68%. The Chimeric Fusion...0 Comentários 0 Compartilhamentos 278 Visualizações 0 Anterior
-
Imfinzi 500mg Injection - a targeted immunotherapy for advanced cancer treatmentIt is an immunotherapy medication used to treat certain cancer types like non-small cell lung cancer, liver and biliary tract cancer. Imfinzi 500mg Injection contain an active ingredient called durvalumab that works to block PD-L1 protein so that immune system gets activated to kill cancer cells. Uses It can treat- Lung cancer(non small cell lung cancer/small cell lung cancer)...0 Comentários 0 Compartilhamentos 308 Visualizações 0 Anterior
-
India Cancer Immunotherapy Market: Innovations Driving Next-Generation Cancer SolutionsAs competition intensifies in the India Cancer Immunotherapy Market, innovation has become the primary differentiator for market players. Both domestic and multinational companies are racing to capture market share by offering novel therapies that cater to the diverse and specific needs of the Indian patient population. The current competitive landscape is marked by a blend of aggressive...0 Comentários 0 Compartilhamentos 383 Visualizações 0 Anterior
-
Leukocyte Surface Antigen CD47 Antibody Market – Immune Checkpoint Research Advancing Cancer ImmunotherapyMarket Overview The leukocyte surface antigen CD47 antibody market is expanding as researchers target the "don't eat me" signal that cancer cells exploit to evade macrophage-mediated immune clearance. CD47-blocking antibodies aim to restore the innate immune system's ability to recognize and eliminate malignant cells, representing a complementary mechanism to T-cell-focused checkpoint...0 Comentários 0 Compartilhamentos 225 Visualizações 0 Anterior
-
Tislelizumab Injection Market: A Rising Star in Cancer ImmunotherapyThe global tislelizumab injection market is experiencing remarkable growth, driven by the increasing incidence of cancer, advancements in immunotherapy, and the rising demand for effective treatment options. Tislelizumab, a humanized monoclonal antibody targeting PD-1, has emerged as a promising immune checkpoint inhibitor for the treatment of various cancers, including non-small cell lung...0 Comentários 0 Compartilhamentos 219 Visualizações 0 Anterior
-
Cytokine Market Insights and Strategic Industry AnalysisThe growing focus on immunology, targeted therapies, and advanced biologics is significantly driving the expansion of the cytokine industry worldwide. Cytokines play a vital role in regulating immune responses, inflammation, and cell signaling, making them essential in the treatment of cancer, autoimmune disorders, infectious diseases, and inflammatory conditions. Increasing investments in...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Intravesical Bacillus Calmette Market Growth Supported by Healthcare AdvancementsThe global intravesical Bacillus Calmette market is experiencing significant growth due to the increasing prevalence of bladder cancer and the rising adoption of immunotherapy-based treatment approaches. Intravesical Bacillus Calmette therapy has become one of the most widely used treatment options for non-muscle invasive bladder cancer (NMIBC), offering effective recurrence prevention and...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Lymphoma Treatment Market Growth Potential Driven by Advances in Cancer TherapeuticsThe lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Tecentriq Market Demand Analysis Across Oncology SectorThe global oncology therapeutics industry is experiencing rapid advancement due to the increasing prevalence of cancer and the growing adoption of immunotherapy-based treatments. Tecentriq, an immunotherapy drug widely used in cancer treatment, has gained strong recognition for its effectiveness in managing various forms of cancer, including lung cancer and urothelial carcinoma. The increasing...0 Comentários 0 Compartilhamentos 863 Visualizações 0 Anterior
-
United States Cancer Immunotherapy Market Size Projected to Reach USD 82,067.9 Million by 2034 with a CAGR of 9.84%IMARC Group has recently released a new research study titled “United States Cancer Immunotherapy Market Report by Therapy Type, Application, End User, and Region, 2026-2034,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. United States Cancer Immunotherapy...0 Comentários 0 Compartilhamentos 499 Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek